[go: up one dir, main page]

DE69725861D1 - Katalytische nukleinsäuren und deren medizinische verwendung - Google Patents

Katalytische nukleinsäuren und deren medizinische verwendung

Info

Publication number
DE69725861D1
DE69725861D1 DE69725861T DE69725861T DE69725861D1 DE 69725861 D1 DE69725861 D1 DE 69725861D1 DE 69725861 T DE69725861 T DE 69725861T DE 69725861 T DE69725861 T DE 69725861T DE 69725861 D1 DE69725861 D1 DE 69725861D1
Authority
DE
Germany
Prior art keywords
molecules
nucleic acids
medical use
catalytic nucleic
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69725861T
Other languages
English (en)
Other versions
DE69725861T2 (de
Inventor
Nathan Asher
Yaron Tikochinski
Andy Ellington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENETICO Ltd
Original Assignee
GENETICO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL119135A external-priority patent/IL119135A/en
Priority claimed from IL12046697A external-priority patent/IL120466A0/xx
Application filed by GENETICO Ltd filed Critical GENETICO Ltd
Publication of DE69725861D1 publication Critical patent/DE69725861D1/de
Application granted granted Critical
Publication of DE69725861T2 publication Critical patent/DE69725861T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1048SELEX
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/124Type of nucleic acid catalytic nucleic acids, e.g. ribozymes based on group I or II introns
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/30Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/337Ribozyme

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69725861T 1996-08-26 1997-08-26 Katalytische nukleinsäuren und deren medizinische verwendung Expired - Fee Related DE69725861T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL119135A IL119135A (en) 1996-08-26 1996-08-26 Catalytic nucleic acid molecules
IL11913596 1996-08-26
IL12046697A IL120466A0 (en) 1997-03-17 1997-03-17 In vitro evolution of oligonucleotides
IL12046697 1997-03-17
PCT/IL1997/000282 WO1998008974A2 (en) 1996-08-26 1997-08-26 Catalytic nucleic acid and its medical use

Publications (2)

Publication Number Publication Date
DE69725861D1 true DE69725861D1 (de) 2003-12-04
DE69725861T2 DE69725861T2 (de) 2004-08-19

Family

ID=26323298

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69735684T Expired - Fee Related DE69735684T2 (de) 1996-08-26 1997-08-26 Katalytische Nukleinsäure und deren medizinische Verwendung
DE69725861T Expired - Fee Related DE69725861T2 (de) 1996-08-26 1997-08-26 Katalytische nukleinsäuren und deren medizinische verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69735684T Expired - Fee Related DE69735684T2 (de) 1996-08-26 1997-08-26 Katalytische Nukleinsäure und deren medizinische Verwendung

Country Status (11)

Country Link
US (1) US6387617B1 (de)
EP (2) EP1350854B1 (de)
JP (1) JP2000517181A (de)
CN (1) CN1232509A (de)
AT (2) ATE323180T1 (de)
AU (1) AU717736B2 (de)
CA (1) CA2264246A1 (de)
DE (2) DE69735684T2 (de)
NO (1) NO990850L (de)
NZ (1) NZ334492A (de)
WO (1) WO1998008974A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514913A (ja) 1996-12-19 2002-05-21 エール ユニバーシティ 生反応性アロステリックポリヌクレオチド
IL120714A0 (en) * 1997-04-21 1997-08-14 Intelligene Ltd Continuous in vitro evolution of oligonucleotides
AU756301B2 (en) * 1997-08-20 2003-01-09 Somagenics, Inc. Antisense and antigene therapeutics with improved binding properties and methods for their use
IL126732A0 (en) * 1998-10-23 1999-08-17 Intelligene Ltd Pro drug
AU6522599A (en) * 1998-10-23 2000-05-15 Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression
IL126731A0 (en) * 1998-10-23 1999-08-17 Intelligene Ltd A method of detection
IL130606A0 (en) * 1999-06-23 2000-06-01 Intelligene Ltd An array of nucleic acid sequence
US6506887B1 (en) 1999-07-29 2003-01-14 Somalogic, Incorporated Conditional-selex
IL132710A0 (en) * 1999-11-02 2001-03-19 Intelligene Ltd Catalytic nucleic acid sequences
EP1290154A2 (de) * 2000-03-01 2003-03-12 Amgen Inc. Identifizierung und verwendung von effektoren und allosterischen molekülen zur änderung der genexpression
WO2001096541A2 (en) * 2000-06-15 2001-12-20 Board Of Regents Allosterically regulated ribozymes
US20030104520A1 (en) * 2000-06-15 2003-06-05 Ellington Andrew D. Regulatable, catalytically active nucleic acids
US6706474B1 (en) * 2000-06-27 2004-03-16 Board Of Trustees Of The University Of Illinois Nucleic acid enzyme biosensors for ions
US7125660B2 (en) 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
US20030219422A1 (en) * 2001-11-15 2003-11-27 Noxxon Pharma Ag Allosteric ribozymes and uses thereof
US6890719B2 (en) 2002-05-10 2005-05-10 The Board Of Trustess Of The University Of Illinois Fluorescence based biosensor
ATE516366T1 (de) 2002-07-25 2011-07-15 Archemix Corp Regulierte aptamer-therapeutika
US10100316B2 (en) 2002-11-21 2018-10-16 Archemix Llc Aptamers comprising CPG motifs
US8039443B2 (en) 2002-11-21 2011-10-18 Archemix Corporation Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
WO2004055199A2 (en) * 2002-12-12 2004-07-01 Chiron Corporation A biological sample storage device and method for biological sample contamination testing
US7309589B2 (en) 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
US7892734B2 (en) * 2005-08-11 2011-02-22 The Board Of Trustees Of The University Of Illinois Aptamer based colorimetric sensor systems
WO2007109500A1 (en) * 2006-03-16 2007-09-27 The Board Of Trustees Of The University Of Illinois Lateral flow devices
US8415461B2 (en) * 2007-01-19 2013-04-09 The Board Of Trustees Of The University Of Illinois Amphiphilic substances and functionalized lipid vesicles including the same
US20080207885A1 (en) * 2007-02-23 2008-08-28 Silverman Scott K Method for site-specific labeling of RNA using a deoxyribozyme
US8058415B2 (en) * 2007-04-24 2011-11-15 The Board Of Trustees Of The University Of Illinois Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
WO2009012309A2 (en) * 2007-07-16 2009-01-22 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for divalent copper ion detection
US8568690B2 (en) * 2007-07-31 2013-10-29 The Board Of Trustees Of The University Of Illinois MRI contrast agents and high-throughput screening by MRI
US8367416B2 (en) 2007-08-10 2013-02-05 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for mercury detection
US20100105039A1 (en) * 2008-06-03 2010-04-29 Yi Lu Label-free colorimetric detection
US8062893B2 (en) 2008-10-10 2011-11-22 The Board Of Trustees Of The University Of Illinois Fluorescent sensor for mercury
US20100305197A1 (en) * 2009-02-05 2010-12-02 Massachusetts Institute Of Technology Conditionally Active Ribozymes And Uses Thereof
US8815156B2 (en) 2010-07-19 2014-08-26 Andalyze, Inc. Sensor housing and reagent chemistry
CA2856116A1 (en) * 2011-11-17 2013-05-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Therapeutic rna switches compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3276955B2 (ja) 1988-09-30 2002-04-22 ジーン−トラック・システムス Rnaの鋳型の末端に結合したプローブ構造およびその使用方法
ATE217347T1 (de) * 1992-12-04 2002-05-15 Univ Yale Diagnose mittels signalverstärkung durch ein ribozym
JPH08507203A (ja) 1992-12-04 1996-08-06 イノーバー ラボラトリーズ,インコーポレイテッド 調節可能な核酸治療およびそれらの使用方法
US5807718A (en) * 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
DE69532525T2 (de) 1995-02-03 2007-02-08 Denso Corp., Kariya Filter
AU697317B2 (en) * 1995-02-27 1998-10-01 Intelligene Ltd. Detection of biomolecules

Also Published As

Publication number Publication date
NO990850L (no) 1999-04-23
JP2000517181A (ja) 2000-12-26
AU717736B2 (en) 2000-03-30
EP1350854B1 (de) 2006-04-12
NO990850D0 (no) 1999-02-23
CN1232509A (zh) 1999-10-20
EP1350854A1 (de) 2003-10-08
NZ334492A (en) 2000-09-29
EP0922114B1 (de) 2003-10-29
US6387617B1 (en) 2002-05-14
DE69735684D1 (de) 2006-05-24
ATE253128T1 (de) 2003-11-15
EP0922114A2 (de) 1999-06-16
CA2264246A1 (en) 1998-03-05
AU3862097A (en) 1998-03-19
DE69735684T2 (de) 2007-04-05
ATE323180T1 (de) 2006-04-15
DE69725861T2 (de) 2004-08-19
WO1998008974A3 (en) 1998-07-02
WO1998008974A2 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
DE69725861D1 (de) Katalytische nukleinsäuren und deren medizinische verwendung
DK1100880T3 (da) Urat oxidase
NZ289720A (en) Nucleic acids coding for a telomerase, a ribonucleoprotein enzyme involved in telomere synthesis
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
ES2085245T3 (es) Procedimiento de purificacion de acidos nucleicos.
PT87083A (pt) Vascular-antikoaquilierende proteine dna die diese kodieren verfahren zu deren herstellung sowie deren verwendung
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
ATE374034T1 (de) Konditioniertes medium und diffusionsfähiges biologisches material gewonnen durch inkubierung von eingeschlossenen zellen
BR0001342A (pt) Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes
BR0000698A (pt) 15, 15'-dioxigenases de beta, beta-caroteno
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
ATE229069T1 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
EP1191096A4 (de) Neues protein und dessen dns
DE59809481D1 (de) Verfahren zur Herstellung von Aminocyanacetamid
ATA47694A (de) Enzymatisches oxidationsverfahren zur umsetzung von cephalosporin c in glutaryl-7- aminocephalosporansäure
TW276191B (en) Catalyst for production of acrylic acid and method for production of acrylic acid by the use of the catalyst
MX9709596A (es) Adn catal ??tico.
PT97820A (pt) Processo de obtencao de proteina map2-quinases, de microorganismos e linhas de celulas compreendendo moleculas recombinantes de map2-quinase e de detencao da presenca de actividade de factores celulares

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee